BSE · ANL
Accretion Nutraveda Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,374
of 5,004 stocks
🏆 New peak
▲ 481W
Peak #2,374 · 01 Oct 2026
A microcap name in Healthcare, Accretion Nutraveda Limited is growing revenue rapidly, remains firmly promoter-controlled, with promoters holding 73%, and commands a premium earnings multiple.
Market Cap
220.82 Cr
P/E Ratio
43.57
P/B Ratio
6.22
ROE
14.29%
ROCE
16.98%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
Quarterly financials for this stock haven't been ingested yet — check back soon.
Shareholding pattern
Promoter
73.48%
Public
26.52%
PUBLIC BREAKDOWN
FII
1.08%
DII
6.10%
Individuals
15.85%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.